Genetically Modified Pig Kidneys Bridge Two Patients to Human Kidney Transplants, NPR Reports

Genetically modified pig kidneys kept two patients with kidney failure alive long enough for them to subsequently receive human kidney transplants, marking what NPR Health described as the first instance of this outcome.

According to the report, the pig kidneys served as a bridge therapy, sustaining the patients during a period when they awaited compatible human organs for transplant.

The development is part of a broader effort by researchers and medical teams to explore xenotransplantation—the use of genetically modified animal organs in humans—as a potential solution to the shortage of donor organs available for patients with kidney failure.

NPR Health did not provide additional details in the excerpt regarding the identities of the patients, the medical institutions involved, or the specific genetic modifications made to the pig kidneys used in the procedures.

The report signals continued progress in a field that has drawn significant attention in recent years as scientists seek alternatives to address long waiting lists for human organ transplants.